Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital.

Abstract:

:Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The likelihood of these serious events is increased in individuals with pain severe enough to require assessment in hospital or a SLEDAI score > 5. This paper describes a group of patients with active SLE and GI symptoms severe enough to require admission to hospital using a retrospective review of 52 SLE patients admitted to hospital with acute abdominal symptoms. The results showed that abdominal pain (87%), vomiting (82%) and diarrhoea (67%) had been present for a mean of 4.4 +/- 6.5 days and SLEDAI score was > or = 4 in 83% of patients. CT scanning showed evidence of serositis and bowel involvement in 63% of patients who underwent this investigation. Intravenous (iv) fluids were used in 87%, parenteral steroids in 90% and iv cyclophosphamide in 31%. Most (n = 51) were discharged well. Recurrence of GI symptoms occurred in 12 patients. The conclusions are that active SLE may manifest as an acute gastrointestinal syndrome. Early diagnosis, bowel rest, supportive medical therapy and treatment with corticosteroids and/or immunosupressives can result in a good outcome.

journal_name

Lupus

journal_title

Lupus

authors

Lian TY,Edwards CJ,Chan SP,Chng HH

doi

10.1191/0961203303lu433oa

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

612-6

issue

8

eissn

0961-2033

issn

1477-0962

journal_volume

12

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.

    abstract::Legionnaire's disease (LD) is most commonly caused by Legionella pneumophila (L. pneumophila). In immunocompromised patients LD can cause necrosis of the lung parenchyma with abscess formation and cavitation. Systemic lupus erythematosus (SLE) is an autoimmune disorder with features of both primary and secondary immun...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203321990102

    authors: Khokher W,Kesireddy N,Adunse J,Mudiyanselage PH,Iftikhar S,Assaly R

    更新日期:2021-01-26 00:00:00

  • Vaccination, atherosclerosis and systemic lupus erythematosus.

    abstract::Atherosclerosis is an inflammatory disease, leading to the formation of pro-inflammatory and pro-oxidative lipids that generate an immune response. Several antigens have been shown to activate the immune response and affect the development of atherogenesis. Systemic lupus erythematosus is an autoimmune and inflammator...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345725

    authors: Carvalho JF,Pereira RM,Shoenfeld Y

    更新日期:2009-11-01 00:00:00

  • Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus.

    abstract:BACKGROUND:Patients with systemic lupus erythematosus (SLE) are at a high risk for cardiovascular disease (CVD) due to increased prevalence of traditional and nontraditional CVD risks factors. OBJECTIVE:To evaluate the effect of patient-centered nutrition counseling methods on changes in select nutrient, anthropometri...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315582284

    authors: Everett ST,Wolf R,Contento I,Haiduc V,Richey M,Erkan D

    更新日期:2015-10-01 00:00:00

  • Repeated miscarriages in patients with antiphospholipid syndrome and subjected to in vitro fertilization: the importance of preimplantation genetic diagnosis.

    abstract::The aim of this study was to investigate two patients with antiphospholipid syndrome (APS) who suffered from multiple repeated pregnancy losses of probably genetically impaired embryos. Sera from these patients contained high levels of IgG antibodies against cardiolipin, IgG and IgM phosphatidyl inositol, IgG phosphat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312442581

    authors: Ulcova-Gallova Z

    更新日期:2012-06-01 00:00:00

  • Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.

    abstract::Mesenchymal stem cells have been applied to treat graft versus host disease as they have immunosuppressive ability and can overcome the major histocompatibility complex-histocompatibility barrier. The potential of allogeneic mesenchymal stem cells in treating systemic lupus erythematosus (SLE) was investigated in this...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320928419

    authors: Liu F,Chen H,Chen T,Lau CS,Yu FX,Chen K,Chen HP,Pan RS,Chan GC,Zhang XY,Nie YJ

    更新日期:2020-07-01 00:00:00

  • Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

    abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312444172

    authors: De Carolis S,Botta A,Santucci S,Salvi S,Moresi S,Di Pasquo E,Del Sordo G,Martino C

    更新日期:2012-06-01 00:00:00

  • Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.

    abstract::Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of e...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309358187

    authors: Ortega LM,Schultz DR,Lenz O,Pardo V,Contreras GN

    更新日期:2010-04-01 00:00:00

  • Antiphospholipid syndrome: clinical and therapeutic aspects.

    abstract::The purpose of the present study was to evaluate patients with the antiphospholipid syndrome with particular attention to their initial clinical features, final diagnoses and the course of thrombotic events in association with therapy. The methodology applied was the following: retrospective analysis of 30 patient fil...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300206

    authors: Vlachoyiannopoulos PG,Tsiakou E,Chalevelakis G,Raptis SA,Moutsopoulos HM

    更新日期:1994-04-01 00:00:00

  • Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.

    abstract::In vitro data showed that immunoglobulin G (IgG) from lupus nephritis (LN) patients could bind to proximal renal tubular epithelial cells (PTEC), but the clinical relevance of such binding remained unclear. Binding of IgG and subclasses to PTEC was measured by cellular ELISA (expressed as OD index) in 189 serial serum...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315598018

    authors: Yap DY,Yung S,Zhang Q,Tang C,Chan TM

    更新日期:2016-01-01 00:00:00

  • Superior mesenteric artery syndrome and intra-abdominal compartment syndrome in systemic lupus erythematosus.

    abstract::Gastrointestinal manifestations of systemic lupus erythematosus (SLE) are common, occurring in about 50% of cases. They are usually mild, in the form of mouth ulcers, nausea, heartburn and mild abdominal pain, but they can be severe in cases of gastrointestinal vasculitis. In this report we describe an unusual combina...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313517150

    authors: Bedaiwi M,Alkubeyyer MA,Al Arfaj AS

    更新日期:2014-02-01 00:00:00

  • Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

    abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314560207

    authors: De Carolis MP,Salvi S,Botta A,Cocca C,Garufi C,Lanzone A,De Carolis S

    更新日期:2015-03-01 00:00:00

  • Systemic lupus erythematosus pregnancies: a case series from a tertiary, East Malaysian hospital.

    abstract::We performed a retrospective study of all systemic lupus erythematosus (SLE) pregnancies during a two-year period (2006-2007) to describe the clinical features, maternal and foetal outcomes in our centre. There were 17 pregnancies in 16 women with SLE. Our patients have a mean age of 28.31 years (SD 5.24) and a mean d...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308096661

    authors: Teh CL,Wong JS,Ngeh NK,Loh WL

    更新日期:2009-03-01 00:00:00

  • Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.

    abstract::Objectives We analyzed the clinical follow-up results of 88 lupus nephritis patients to find prognostic factors for the development of chronic kidney disease in ethnically homogeneous Korean patients with biopsy-proven lupus nephritis. Methods Sociodemographic, clinical, laboratory, and treatment-related data at the t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317694257

    authors: Park DJ,Kang JH,Lee JW,Lee KE,Kim TJ,Park YW,Lee JS,Choi YD,Lee SS

    更新日期:2017-10-01 00:00:00

  • Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

    abstract:OBJECTIVE:The aim of this study was to determine whether the functional CD40 rs4810485 G/T polymorphism is associated with susceptibility to rheumatoid arthritis (RA) or with susceptibility to systemic lupus erythematosus (SLE). METHODS:A series of meta-analyses were conducted to test for association between the CD40 ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203315583543

    authors: Lee YH,Bae SC,Choi SJ,Ji JD,Song GG

    更新日期:2015-10-01 00:00:00

  • Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.

    abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320911091

    authors: Juthong S,Geater AF,Dekumyoy P,Hortiwakul T,Siripaitoon B,Aiewruengsurat D,Thongbun N

    更新日期:2020-05-01 00:00:00

  • Cat scratch disease (bartonellosis) mimicking an SLE flare.

    abstract::Only recently Bartonella species have been recognized as important human pathogens. Cat scratch disease (CSD), caused by infection with Bartonella henselae, shows a steady increase in the number of cases throughout the world. We report a case of an 18-year-old woman with systemic lupus erythematosus (SLE) who presente...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301701548373

    authors: Gaubitz M,Herrmann M,Shahin M,Schotte H,Willeke P,Domschke W

    更新日期:2001-01-01 00:00:00

  • The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus.

    abstract::The aim of the study is to investigate whether the functional p53 codon 72 polymorphism is associated with susceptibility to SLE and its clinical features. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 90 SLE patients and 114 ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2224oa

    authors: Lee YH,Rho YH,Choi SJ,Ji JD,Song GG

    更新日期:2005-01-01 00:00:00

  • Lower kidney allograft survival in African-Americans compared to Hispanic-Americans with lupus.

    abstract::Background and objective African-Americans and Hispanic-Americans with lupus are the two most common minority groups who receive kidney transplants in the USA. It is unknown if African-Americans and Hispanic-Americans with lupus have similar outcomes after kidney transplantation. In this study, we assessed whether Afr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317699287

    authors: Gonzalez-Suarez ML,Contreras G

    更新日期:2017-10-01 00:00:00

  • Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice.

    abstract::Therapeutic agents currently in use to treat systemic lupus erythematosus (SLE) are predominantly immunosuppressive agents with limited specificities. Multiple groups, including ours, have illustrated that inducing tolerance in SLE animal models ameliorates disease symptoms and increases survival. We examined if oral ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311398509

    authors: Skaggs BJ,Lourenço EV,Hahn BH

    更新日期:2011-08-01 00:00:00

  • Twenty-year follow-up: an unusual case of nephropathy of antiphospholipid syndrome.

    abstract::Nephropathy of antiphospholipid antibody syndrome (NAPS) is an increasingly well-recognized aspect of antiphospholipid syndrome. The most characteristic histopathology is that of thrombotic microangiopathy, and thrombosis occurring in the renal vasculature is thought to be the initiating event. Other less common patho...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308098629

    authors: Lin YQ,Lakshminarayanan S,Yamase H,Palmisano J,Parke A

    更新日期:2009-05-01 00:00:00

  • Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile.

    abstract::We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster collaboration among health professionals regarding the diagnosis and management of antiphospholipid syndrome (APS) patients. This cohort-study (APS Piedmont Cohort) ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312446974

    authors: Bertero MT,Bazzan M,Carignola R,Montaruli B,Silvestro E,Sciascia S,Vaccarino A,Baldovino S,Roccatello D,Antiphospholipid Piedmont Consortium.

    更新日期:2012-06-01 00:00:00

  • Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.

    abstract::Lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) is a rare acquired disorder caused by prothrombin antibodies. The disease is most common in the pediatric age group (<16 years), and more prevalent in women. There are well-established clinical diseases associated with LA-HPS, most notably systemic lupus erythe...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314558859

    authors: Mulliez SM,De Keyser F,Verbist C,Vantilborgh A,Wijns W,Beukinga I,Devreese KM

    更新日期:2015-06-01 00:00:00

  • The blood-brain barrier in systemic lupus erythematosus.

    abstract::Central nervous system (CNS) involvement may occur in 20-70% of systemic lupus erythematosus (SLE) patients where neurological symptoms are overt; this is termed neuropsychiatric lupus or NPSLE. This review summarizes evidence that damage to the brain endothelium forming the blood-brain barrier (BBB) is a contributory...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu501oa

    authors: Abbott NJ,Mendonça LL,Dolman DE

    更新日期:2003-01-01 00:00:00

  • Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE.

    abstract::A girl with neuropsychiatric lupus demonstrated Parkinsonian features soon after commencing risperidone. The single photon emission computed tomography scan showed hyperperfusion of the basal ganglia. Symptoms abated with the addition of dopaminergic agents to immunosuppressive therapy. The literature on juvenile Park...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307081421

    authors: Khubchandani RP,Viswanathan V,Desai J

    更新日期:2007-01-01 00:00:00

  • GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.

    abstract:BACKGROUND:GlycA is a novel marker of systemic inflammation detected by nuclear magnetic resonance (NMR) spectroscopy. In the general population, GlycA is correlated with inflammatory markers such as C-reactive protein (CRP) and associated with coronary heart disease and diabetes. The utility of GlycA in patients with ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617842

    authors: Chung CP,Ormseth MJ,Connelly MA,Oeser A,Solus JF,Otvos JD,Raggi P,Stein CM

    更新日期:2016-03-01 00:00:00

  • Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.

    abstract::We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker f...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400414

    authors: Stojanov L,Satoh M,Dooley MA,Kuwana M,Jennette JC,Reeves WH

    更新日期:1995-08-01 00:00:00

  • Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

    abstract:BACKGROUND:Ferritin is an iron storage protein considered also as an acute phase reactant with high levels in various inflammatory conditions. Recently, a plausible role for ferritin in the pathogenesis of immune-mediated and especially autoimmune diseases has been suggested. However, the link between ferritin and the ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313504633

    authors: Agmon-Levin N,Rosário C,Katz BS,Zandman-Goddard G,Meroni P,Cervera R,Stojanovich L,Blank M,Pierangeli S,Praprotnik S,Meis Ed,Seguro LP,Ruffatti A,Pengo V,Tincani A,Doria A,Shoenfeld Y

    更新日期:2013-11-01 00:00:00

  • Olanzapine-induced neutropenia in a patient with systemiclupus erythematosus: a role of FcγRIIIb polymorphism?

    abstract::In this study, we report the case of a Chinese patient with systemic lupus erythematosus (SLE) who developed neutropenia after treatment by olanzapine for the SLE-related psychiatric symptoms. The relationship between agranulocytosis, SLE and olanzapine is still unknown. Fcγ receptor IIIb (FcγRIIIb) is a low-affinity ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311415889

    authors: Salviati M,Ortona E,Colasanti T,Francia A,Pontecorvo S,Delle Chiaie R

    更新日期:2012-01-01 00:00:00

  • Atherosclerosis and autoimmunity.

    abstract::Novel risk factors for the progression of atherosclerosis such as C-reactive protein (CRP) and adhesion molecules have stimulated much recent interest in the role of inflammation in atherosclerotic disease. There is also evidence emerging that autoimmunity may have a role in the pathogenesis of atherosclerosis. In thi...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301680416922

    authors: Gordon PA,George J,Khamashta MA,Harats D,Hughes G,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina.

    abstract:OBJECTIVE:To describe clinical effectiveness of belimumab for systemic lupus erythematosus (SLE) in real-world practice in Argentina. METHODS:This retrospective, observational study analysed medical record data of patients with SLE treated with belimumab in 15 centres in Argentina. Primary endpoint: overall clinical r...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320947814

    authors: Babini A,Cappuccio AM,Caprarulo C,Casado G,Eimon A,Figueredo H,García MA,Magri S,Mannucci P,Perez Rodriguez S,Pons-Estel BA,Velozo EJ,Iglesias-Rodriguez M,Streger G

    更新日期:2020-10-01 00:00:00